🇺🇸 FDA
Patent

US 8283370

Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

granted A61PA61P29/00A61P31/04

Quick answer

US patent 8283370 (Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use) held by The United States of America as represented by the Secretary of the Army expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00, A61P31/04, A61P33/06